Jagsonpal Pharmaceuticals

Quarterly
Consolidated
ParticularsSep '26
Revenue98.62
Expenses81.97
EBITDA19.16
EBIT16.71
Profit Before Tax16.42
Net Profit12.29
Financial Ratios
Operating Profit Margin19.63%
Net Profit Margin12.94%
Earning Per Share (Diluted)1.83
Dividends Per Share0.00